Okla. Stat. tit. 36, § 36-3614.4
This is the official text of Okla. Stat. tit. 36, § 36-3614.4, part of Oklahoma’s Stat. tit. 36, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 36,." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Disclosure of genetic research studies
Official statutory text
A. This section shall be known and may be cited as the “Genetic
Research Studies Nondisclosure Act”.
B. For purposes of the Genetic Research Studies Nondisclosure
Act, “genetic research study or studies” shall mean those genetic
research studies approved by an institutional review board as
defined in 21 CFR, Section 50 or conducted subject to the
requirements of the federal common rule at 21 CFR, Section 50 and
Section 56, and 45 CFR, Section 46.
C. All research records of individual subjects in genetic
research studies shall be confidential, meaning the records shall
not be subject to subpoena or discovery in civil suits, except in
cases where the information in the records is the basis of the suit.
The records shall not be disclosed to employers or health insurers
without the informed consent of the subject.
D. Notwithstanding any language in this section to the
contrary, this section shall not apply to an insurer or to an
individual or third party dealing with an insurer in the ordinary
course of underwriting, conducting or administering the business of
life, disability income or long-term care insurance or in connection
with any judicial, legislative or administrative proceeding relating
to life, disability income or long-term care insurance. Nothing in
this section is intended to govern an insurer or to govern an
individual or third party dealing with an insurer in connection with
the obtaining, maintaining, use, disclosure or redisclosure of
genetic information or the results of a genetic test, including but
not limited to records of individual subjects in genetic research in
connection with life, disability income or long-term care insurance
or in connection with any judicial, legislative or administrative
proceeding relating to life, disability income or long-term care
insurance.
E. All stored tissues, including blood, that arise from
surgery, other diagnostic or therapeutic steps, or autopsy may be
disclosed for genetic or other research studies if informed consent
has been obtained. Informed consent may be included in a section of
the consent for treatment, admission to a hospital or clinic, or
permission for an autopsy and no other consent shall be required.
F. It shall be permissible to publish or otherwise use the
results of genetic research studies for research or educational
purposes if no individual subject is identified. If specific
informed consent from the individual has been obtained, the
individual may be identified.
Research Studies Nondisclosure Act”.
B. For purposes of the Genetic Research Studies Nondisclosure
Act, “genetic research study or studies” shall mean those genetic
research studies approved by an institutional review board as
defined in 21 CFR, Section 50 or conducted subject to the
requirements of the federal common rule at 21 CFR, Section 50 and
Section 56, and 45 CFR, Section 46.
C. All research records of individual subjects in genetic
research studies shall be confidential, meaning the records shall
not be subject to subpoena or discovery in civil suits, except in
cases where the information in the records is the basis of the suit.
The records shall not be disclosed to employers or health insurers
without the informed consent of the subject.
D. Notwithstanding any language in this section to the
contrary, this section shall not apply to an insurer or to an
individual or third party dealing with an insurer in the ordinary
course of underwriting, conducting or administering the business of
life, disability income or long-term care insurance or in connection
with any judicial, legislative or administrative proceeding relating
to life, disability income or long-term care insurance. Nothing in
this section is intended to govern an insurer or to govern an
individual or third party dealing with an insurer in connection with
the obtaining, maintaining, use, disclosure or redisclosure of
genetic information or the results of a genetic test, including but
not limited to records of individual subjects in genetic research in
connection with life, disability income or long-term care insurance
or in connection with any judicial, legislative or administrative
proceeding relating to life, disability income or long-term care
insurance.
E. All stored tissues, including blood, that arise from
surgery, other diagnostic or therapeutic steps, or autopsy may be
disclosed for genetic or other research studies if informed consent
has been obtained. Informed consent may be included in a section of
the consent for treatment, admission to a hospital or clinic, or
permission for an autopsy and no other consent shall be required.
F. It shall be permissible to publish or otherwise use the
results of genetic research studies for research or educational
purposes if no individual subject is identified. If specific
informed consent from the individual has been obtained, the
individual may be identified.
Status: in_force · Read it on the official government site
Need a lawyer in Oklahoma?
Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.